论文部分内容阅读
利用BUCY2方案作预处理对2例急性白血病患者实施同种异基因骨髓移植,输入的供体骨髓分别于术后第18天和17天植活;BUCY2预处理方案的毒性较小,化疗反应较易耐受72例患者均于术后第18天出现急性移植物抗宿主病(GVHD,Ⅱ级),现已持久植活达2年和1年半,术后5个月复查时,患者的造血系统仍为供体来源。
Allogeneic bone marrow transplantation was performed on 2 patients with acute leukemia using the BUCY2 protocol as a pretreatment. The input donor bone marrow was engrafted on the 18th and 17th day postoperatively; the BUCY2 pretreatment regimen was less toxic and the chemotherapy response was less All 72 patients with tolerability experienced acute graft-versus-host disease (GVHD, grade II) on the 18th day after surgery. They have been permanently implanted for 2 years and 1 year and a half. During the 5-month follow-up, the patient’s The hematopoietic system remains the source of the donor.